GlycoMimetics's market cap is currently ―. The company's EPS TTM is $-1.03; its P/E ratio is -1.42; GlycoMimetics is scheduled to report earnings on March 29, 2023, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
Income Statement	-
Total Revenue	$ 0.00	$ 75.00K	$ 0.00	$ 17.63K	$ 86.56K
Gross Profit	-	-	-	-	-
EBIT	$ -8.77M	$ -13.35M	$ -14.66M	$ -17.43M	$ -17.34M
EBITDA	$ -8.72M	$ -13.30M	$ -14.60M	$ -17.36M	$ -17.27M
Net Income Common Stockholders	$ -8.52M	$ -13.27M	$ -14.65M	$ -17.42M	$ -17.33M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 51.62M	$ 60.24M	$ 76.52M	$ 90.25M	$ 101.92M
Total Assets	$ 55.96M	$ 65.04M	$ 81.46M	$ 94.35M	$ 107.94M
Total Debt	$ 1.18M	$ 1.43M	$ 1.68M	$ 1.92M	$ 2.15M
Net Debt	$ -50.44M	$ -58.81M	$ -74.84M	$ -88.33M	$ -99.77M
Total Liabilities	$ 7.84M	$ 9.32M	$ 13.43M	$ 12.74M	$ 11.38M
Stockholders Equity	$ 48.12M	$ 55.73M	$ 68.03M	$ 81.60M	$ 96.57M
Cash Flow	-
Free Cash Flow	$ -8.62M	$ -16.27M	$ -13.74M	$ -12.81M	$ -16.95M
Operating Cash Flow	$ -8.62M	$ -16.23M	$ -13.70M	$ -12.81M	$ -16.95M
Investing Cash Flow	$ -2.48K	$ -41.19K	$ -40.52K	$ -2.45K	$ -4.33K
Financing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 1.14M	$ 20.79K

Currency in USD

GlycoMimetics Earnings and Revenue History

Income Statement >

GlycoMimetics Debt to Assets

Balance Sheet >

GlycoMimetics Cash Flow

Cash Flow >

GlycoMimetics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing